Healthcare is evolving and, today, with shifting priorities and system challenges, telehealth is an essential solution. However, for this technology to be truly successful, improved system integration and accurate patient data collection are more critical than ever. Patients want to engage their physicians with comfort and ease from their own homes and physicians want to provide accurate and convenient care.
From this need, Nonagon was born.
Seamlessly integrated at the front and back end of delivery, Nonagon offers a cost-effective, smartphone-compatible device to capture clinically relevant patient data, sent directly to a physician. With Nonagon, physicians can provide an accurate and timely diagnosis and treatment plan to their remote patients — reducing the need for in-clinic visits.
Nonagon offers a user-friendly experience, clinically-relevant data collection and system architecture which integrates with any proprietary system. This is why, with Nonagon, care is always at hand.
NONAGON, formerly known as MyHomeDoc, is a fast-growing medical start-up. Founded in 2016 and graduated Sanara Ventures, a joint Investment Platform of Teva pharmaceuticals and Philips healthcare, The Nonagon company has offices in Israel (HQ) and the United States.
Dr. Amnon Gavish
VP Marketing & Products
A nine-in-one home device includes a stethoscope, otoscope, oximeter and thermometer. For throat and skin tests, N9 uses the patient’s phone camera. The Covid-19 crisis
The Israeli MedTech startup is riding the wave of remote medical solutions, which have gained even more popularity since the outbreak of the COVID-19 pandemic.